Affiliation:
1. Idorsia Pharmaceuticals Ltd Clinical Pharmacology Allschwil Switzerland
Subject
Pharmacology (medical),Pharmacology
Reference34 articles.
1. Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions
2. Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006
3. Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions
4. European Medicines Agency Committee for Medicinal Products for Human Use (CHMP).Guideline on strategies to identify and mitigate risks for first‐in‐human and early clinical trials with investigational medicinal products.https://www.ema.europa.eu/documents/scientific-guideline/guideline-strategies-identify-mitigate-risks-first-human-early-clinical-trials-investigational_en.pdf. Published July 20 2017. Accessed September 17 2019.
5. Estimating the starting dose for entry into humans: principles and practice